Supplementing Therapy With Antioxidant Product In Breast Cancer Treatment

Author

Tran Van Hien, Nguyen Boi Huong, National Hospital of Traditional Medicine, 29 Nguyen binh Khiem Street, Hanoi, Vietnam

Proceeding

1st International Conference & Exhibition on Women's Health & Asian Traditional (WHAT) Medicine

Date

23/8/2005

Keyword

randomized placebo clinical trial, Vitexina, Vigna radiata (L.), antioxidant activities, immunological response

Abstract

Cancer patients undergoing radiotherapy with Coblt-60 are at risk of impaired immune response due to the immune-responsible cells are sensitive to high-energy radiation. The present study is a randomized placebo clinical trial for investigating the effects of Vitexina, derived from a plant, Vigna radiata (L.), possessing antioxidant activities, in recovering in amounts and functions of T-lymphocytes. Treatment with Vitexina for 2 months produced a significant recovery of immune response with an increase of total leukocyte, lymphocyte counts, T-CD4, T-CD8, and in lymphocyte blast-transformation. The findings suggested that the application of Vitexina is beneficial for breast cancer patients at least in aspect of recovering the immunological response.